KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short-Term Debt issuances (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Short-Term Debt issuances for 17 consecutive years, with -$426.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Short-Term Debt issuances fell 116.52% to -$426.0 million in Q3 2025 year-over-year; TTM through Jun 2025 was $3.0 billion, a 6430.43% increase, with the full-year FY2024 number at $3.0 billion, up 2589.17% from a year prior.
  • Short-Term Debt issuances was -$426.0 million for Q3 2025 at Bristol Myers Squibb, down from $58.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $3.0 billion in Q1 2024 to a low of -$2.6 billion in Q2 2024.
  • A 5-year average of $161.2 million and a median of $50.0 million in 2022 define the central range for Short-Term Debt issuances.
  • Peak YoY movement for Short-Term Debt issuances: tumbled 3700.0% in 2021, then skyrocketed 25880.0% in 2024.
  • Bristol Myers Squibb's Short-Term Debt issuances stood at -$114.0 million in 2021, then skyrocketed by 219.3% to $136.0 million in 2022, then crashed by 359.56% to -$353.0 million in 2023, then skyrocketed by 830.31% to $2.6 billion in 2024, then tumbled by 116.52% to -$426.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Short-Term Debt issuances are -$426.0 million (Q3 2025), $58.0 million (Q2 2025), and $368.0 million (Q1 2025).